AVALO THERAPEUTICS INC (AVTX) Stock Analyst Ratings
NASDAQ:AVTX - Nasdaq - US05338F3064 - Common Stock - Currency: USD
ChartMill assigns a Buy % Consensus number of 87% to AVTX. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 32.13. This target is 579.28% above the current price.
AVTX was analyzed by 14 analysts. The buy percentage consensus is at 87. So analysts seem to be very confident about AVTX.
In the last month the buy percentage rose by 44 points. So the trust of analysts is improving.
AVTX was analyzed by 14 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-03-25 | Stifel | Initiate | Buy |
| 2025-03-25 | Jefferies | Initiate | Buy |
| 2025-03-20 | HC Wainwright & Co. | Reiterate | Neutral -> Neutral |
| 2025-02-28 | Piper Sandler | Initiate | Overweight |
| 2024-12-19 | BTIG | Initiate | Buy |
| 2024-12-17 | LUCID CAPITAL MARKETS | Initiate | Buy |
| 2024-10-24 | HC Wainwright & Co. | Initiate | Neutral |
| 2024-04-16 | Oppenheimer | Upgrade | Perform -> Outperform |
| 2023-06-27 | Oppenheimer | Downgrade | Outperform -> Perform |
| 2023-06-27 | RBC Capital | Downgrade | Outperform -> Sector Perform |
| 2023-05-10 | RBC Capital | Maintains | Outperform |
| 2023-02-08 | Jefferies | Downgrade | Hold -> Underperform |
| 2022-03-03 | RBC Capital | Maintains | Outperform |
| 2022-03-03 | Jefferies | Downgrade | Buy -> Hold |
| 2021-09-24 | RBC Capital | Initiate | Outperform |